Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Osmosis, LLC
WARNING LETTER
•Osmosis, LLC•January 13, 2023

Osmosis, LLC – FDA Warning Letter, Jan 13, 2023

Record Details

The FDA issued a Warning Letter to Dr. Benjamin T. Johnson following a January 2023 inspection of their Evergreen, CO facility and a review of product labels and osmosisbeauty.com. The letter identifies serious violations of the Federal Food, Drug, and Cosmetic Act. Osmosis Skin Perfection Elixir, Sugar Detox Elixir, and Elevate products are deemed unapproved new drugs (21 U.S.C. 321(g)(1)(B), 321(p)) due to disease treatment claims (e.g., inflammation, diabetes, cholesterol management). These products are also misbranded (21 U.S.C. § 352(f)(1)) for lacking adequate directions for use, as they address conditions requiring professional supervision. Significant Current Good Manufacturing Practice (CGMP) violations for dietary supplements were found, rendering products adulterated (21 U.S.C. § 342(g)(1)). Deficiencies include failing to establish written procedures for quality control (21 CFR 111.103), equipment maintenance (21 CFR 111.25(c)), product complaints (21 CFR 111.553), returned supplements (21 CFR 111.503), and holding/distribution (21 CFR 111.453). The firm's initial response was inadequate. Furthermore, Osmosis Skin Clarifier, Recovery, Regenerate, Immune Defense Elixir, and Elevate dietary supplements are misbranded (21 U.S.C. § 343) due to various labeling non-compliances. These include failing to provide a domestic address/phone for adverse event reporting (21 U.S.C. § 343(y)), incorrect serving sizes (21 U.S.C § 343(q)(1)(A)), non-compliant nutrition information presentation (21 CFR 101.36), improper statement of identity, missing structure/function claim symbols, and incorrect plant part declarations. The FDA requires a written response within 15 working days detailing corrective actions, warning of potential legal action.

Company
Osmosis, LLC
Inspection date
January 13, 2023
Product type
Food
Office
Division of Human and Animal Food Operations - East IV
Person
  • Mark Harris (E.)
View Company Profile

ID · ba8e52c6-ba45-4c10-99bc-dedcd50d4deb

Violation Codes10
21 U.S.C. 34321 CFR 11121 CFR 111.10321 U.S.C. 343(q)(5)(F)21 CFR 101.12(b)21 CFR 101.3621 U.S.C. 342(g)(1)21 U.S.C. 343(q)(1)(A)21 CFR 101.9(c)(2)21 CFR 111.453

Full citation text and observation details available on the Dashboard.

Other documents for Osmosis, LLC
  • 483 - 2023-01-13January 13, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Osmosis, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.